Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Retrotope

4300 EL CAMINO REAL, SUITE 201,
Los Altos, CA 94022
USA
(650) 917-9256
Website Company Summary Management Team
Management

CEO: Bob Molinari (2007)
Board

Company

Business description: Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope’s platform prevents cellular damage and recovers cellular function damaged by lipid peroxidation due to oxidative stress. Retrotope’s first product candidate, RT001, is being clinically tested in Friedreich’s ataxia (FA), an untreated fatal orphan disease. Other stabilized lipid drugs based on Retrotope’s transformational platform technology have the potential to treat a wide variety of other mitochondrial myopathies and neurodegenerative diseases.
Capital

Rounds: 2
Recent Fundings: Mar 2016
Capital raised: 14.53M
Last Round: 14.53M
Ownership: Private  
Angels/other VCs: Timur Artemev (Euroset)

Last Tweets


 

Last Mentions


Overview
Record updated: Feb 2017
Sector: Medical
Year Founded: 2006
Headcount: 11-25
Rounds: 2
Recent Fundings: Mar 2016
Capital Raised: 14.53M
Last Round: 14.53M
Ownership: Private